Literature DB >> 21397406

Combining carbamazepine, neuroleptics and acetylcholinesterase inhibitors with methylphenidate only reduces adverse side effects, but is less effective than a combination with atomoxetine.

H Niederhofer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21397406     DOI： 10.1016/j.mehy.2011.02.011

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN： 0306-9877            Impact factor:   1.538


× No keyword cloud information.
  2 in total

Review 1.  Attention-deficit/hyperactivity disorder in older adults: prevalence and possible connections to mild cognitive impairment.

Authors:  Nikki Ivanchak; Kristen Fletcher; Gregory A Jicha
Journal:  Curr Psychiatry Rep       Date:  2012-10       Impact factor: 5.285

Review 2.  Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.

Authors:  Ole Jakob Storebø; Nadia Pedersen; Erica Ramstad; Maja Lærke Kielsholm; Signe Sofie Nielsen; Helle B Krogh; Carlos R Moreira-Maia; Frederik L Magnusson; Mathilde Holmskov; Trine Gerner; Maria Skoog; Susanne Rosendal; Camilla Groth; Donna Gillies; Kirsten Buch Rasmussen; Dorothy Gauci; Morris Zwi; Richard Kirubakaran; Sasja J Håkonsen; Lise Aagaard; Erik Simonsen; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2018-05-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.